Allergan, Inc. (NYSE: AGN), the makers of LATISSE® (bimatoprost ophthalmic solution) 0.03%, announced today the launch of the LATISSE® Wishes Challenge campaign. Inspired by the tradition of blowing on an eyelash to make wishes come true, lifestyle designer Kathy Ireland, professional ballroom dancer Chelsie Hightower and style guide Bobbie Thomas will each lead teams of LATISSE® users from across the country who are challenged to raise more than a quarter of a million dollars for the Make-A-Wish Foundation, a nonprofit organization dedicated to granting the wishes of children with life-threatening medical conditions. LATISSE® solution is the first and only prescription treatment approved by the U.S. Food and Drug Administration (FDA) to grow lashes longer, fuller and darker for those with inadequate or not enough lashes (eyelash hypotrichosis).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/latisse/43354/
http://adultadhdtreatmentblog.com/adhd-alternative-treatment/
In recent years, study has brought to light some fairly startling details about using prescription medications to treat ADHD. For this reason, along with other people, many parents are now looking for ADHD alternative treatments for their children. Things like potentially serious side results, unknown long term effects and the increasing expenses of doctor prescribed medications are making an ADHD alternative therapy seem like a better idea each day. In this article, we
http://adultadhdtreatmentblog.com/adult-ritalin-is-this-effective-for-adult-adhd/ Occasionally trying to find an perfect grownup ADHD treatments and adult ritalin is really a seemingly endless array of medical medical doctors visits, medication modifications, and dosage adjustments. I understand your aggravation and share your discomfort. Nevertheless, existence will go on, so we must pick ourselves up and get back concerning the bus in make an effort to find that 1 grownup ADHD treatments that will assist us overcome those problematic grownup ADHD symptoms that may happen to be dogging us for years, for example inattention, impulsive behavior, and restlessness. Whilst this list won’t provide you with a brand new prescription drug alternative, it just might help you to improve your outcomes and minimize people pesky side effects. There
Could migraine patients be doing more to get the most out of their medical visits? According to a new national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline, the answer is yes. For the nearly 30 million migraine sufferers in the U.S., including six million treating with prescription medication, these survey results may have important implications.
The survey, conducted online in November 2010 by Harris Interactive, included 1,218 diagnosed migraine patients taking prescription medications for their migraine attacks as well as 533 physicians who treat between five and 10 migraine patients per week. The findings revealed disparities between what patients and physicians each reported typically discussing during office visits.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/glaxosmithkline/48596/
Upsher-Smith Laboratories, Inc. today announced the nationwide launch of Provella™, a unique probiotic dietary supplement specifically designed for women to promote digestive, feminine, and immune health.* Provella™ helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella™ tablets contain a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, and Bifidobacterium bifidum.
Provella™ is available without a prescription behind the pharmacy counter at retail pharmacies nationwide and online at www.drugstore.com. Consumers can also ask any local pharmacist to order Provella™ using List Number 0245-1060-30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56871-upsher-smith-provella-probiotic-supports-digestive-feminine-immune-health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Golf Lessons Irvine http://www.GolfSwingPrescription.com Call (949) 554-9926 - Are you looking for golf lessons in Irvine (or the nearby area) or just golfing tips in general? Ryan Trengrove (Class A PGA member), owner of a state-of-the-art indoor golf training facility called Golf Swing Prescription (Laguna Hills, CA), shows you how conquer one of the most common problems in Golf - keeping your lower body stable while swinging the golf club!
Ryan states that if you can get your lower body to be more stable, you will have a lot more fun when you are playing golf. Ryan shows you a video of one of Golf’s great player’s, Davis Love III, to display great lower body stability. Ryan points out how Davis’s lower body not only stays in the “same sit” and “same flex” as Davis goes up to the top of his golf swing, but, also when he goes back down to hit the golf ball.
Ryan also points out the importance of NOT having your lower body “sway”, but to have it “swivel” instead. The goal is to keep the lower body in its flex, so that you can have it sit, and keep the hip in the same spot. If you are able to do this, as you come from the top of your swing down to the ball, you should make solid contact.
In order to assist you in achieving better lower body stability, Ryan shows you a golf drill called the “Feet Together Drill”. This drill has the golfer setup to hit the golf ball with their feet together, which will prevent the golfer from going “side to side” during the swing. The idea behind the drill is to have the golfer hit a number of shots with their feet together so that they can get the “feeling” of not “going side to side” and being stable. Once you get use to the feeling, then you can widen your golf stance, trying to maintain the same “stable feeling” felt during the drill, with your base “swiveling” and not “swaying”.
Ryan goes on to show you one more drill to help you that he got from Golf Professional, Nick Faldo called the “Right Foot Forward – Left Leg Back Drill” (just switch if you are left handed). The goal of this drill is to help you focus on keeping the flex in your right knee. You get in your normal golf stance, but, just move your left leg back a couple of feet, and then hit the ball. So what this drill does is to focus you on keeping the proper flex in your right knee.
What Ryan wants you to do is to work on the combination of the “Feet Together Drill” and the “Right Foot Forward –Left Leg Back Drill” so that when you get up to your golf ball you focus on staying centered – no “side to side” and keeping your right knee flexed. Ryan points out that if you can do this, that you should make better contact with the ball!
Ryan performs over 1,500 golf lessons per year, when compared to the average club pro that only conducts approximately 300. Ryan is extremely popular for a reason; his indoor
Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
Eisai Inc. today announced the launch of a new national television advertising campaign for BELVIQ® (lorcaserin HCl) CIV, an FDA-approved prescription therapy for chronic weight management. The advertisement will air on numerous channels including Lifetime, Oxygen and AMC.
The spot illustrates the struggles many people face when they are trying to lose or control their weight. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help some patients lose weight and keep it off.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161051-eisai-launches-national-television-campaign-belviq-lorcaserin-hcl-civ
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Adlens, the global leader in adjustable focus eyewear, has launched its ground-breaking adjustable prescription eyewear ‘AdlensFocuss™’, the greatest advancement in optics in more than 50 years.
Vision inevitably changes with age and people often need different strength glasses to see at near, intermediate and far distances. Progressive lenses are an option but they have a restricted usable lens area. A GFK Roper Study has shown one-third of wearers say they have trouble adjusting to them with seven to eight percent of wearers saying they cannot adjust to them at all.
AdlensFocuss provides the benefits of a single vision lens – full frame viewing area – with the best features of a progressive lens – the ability to see at different distances. They are prescription glasses with proprietary technology; a unique flexible membrane that allows the power to be adjusted by simply turning small dials on the inside of the frames. AdlensFocuss lenses offer at least four times more viewing area than traditional progressive lenses and come encased in a fashion-forward frame from award-winning designer Blake Kuwahara.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544851-adlensfocuss-optics-technology/
